105 related articles for article (PubMed ID: 1682487)
21. Effects of alpha 2-adrenergic drugs on the alcohol consumption of alcohol-preferring rats.
Korpi ER
Pharmacol Toxicol; 1990 Apr; 66(4):283-6. PubMed ID: 1973538
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of medetomidine and atipamezole in dairy calves: an agonist-antagonist interaction.
Ranheim B; Søli NE; Ryeng KA; Arnemo JM; Horsberg TE
J Vet Pharmacol Ther; 1998 Dec; 21(6):428-32. PubMed ID: 9885964
[TBL] [Abstract][Full Text] [Related]
23. Sedative effects of medetomidine and its reversal by atipamezole in llamas.
Waldridge BM; Lin HC; DeGraves FJ; Pugh DG
J Am Vet Med Assoc; 1997 Dec; 211(12):1562-5. PubMed ID: 9412685
[TBL] [Abstract][Full Text] [Related]
24. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
Wei H; Pertovaara A
Anesth Analg; 1997 Nov; 85(5):1122-7. PubMed ID: 9356112
[TBL] [Abstract][Full Text] [Related]
25. Sedative and cardiopulmonary effects of medetomidine hydrochloride and xylazine hydrochloride and their reversal with atipamezole hydrochloride in calves.
Rioja E; Kerr CL; Enouri SS; McDonell WN
Am J Vet Res; 2008 Mar; 69(3):319-29. PubMed ID: 18312129
[TBL] [Abstract][Full Text] [Related]
26. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
[TBL] [Abstract][Full Text] [Related]
27. Medetomidine--a novel alpha 2-adrenoceptor agonist: a review of its pharmacodynamic effects.
Scheinin H; Virtanen R; MacDonald E; Lammintausta R; Scheinin M
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):635-51. PubMed ID: 2571177
[TBL] [Abstract][Full Text] [Related]
28. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release.
Raiteri M; Maura G; Versace P
J Pharmacol Exp Ther; 1983 Mar; 224(3):679-84. PubMed ID: 6298406
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
[TBL] [Abstract][Full Text] [Related]
30. Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.
Koulu M; Pesonen U; Koskinen S; Scheinin H; Virtanen R; Scheinin M
Pharmacol Toxicol; 1993 Mar; 72(3):182-7. PubMed ID: 8100065
[TBL] [Abstract][Full Text] [Related]
31. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
Schwinn DA; Correa-Sales C; Page SO; Maze M
J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
[TBL] [Abstract][Full Text] [Related]
32. The effects of ethanol in combination with the alpha 2-adrenoceptor agonist dexmedetomidine and the alpha 2-adrenoceptor antagonist atipamezole on brain monoamine metabolites and motor performance of mice.
Idänpään-Heikkilä JJ; Björn M; Seppälä T
Eur J Pharmacol; 1995 Jan; 292(2):191-9. PubMed ID: 7536679
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats.
Haapalinna A; MacDonald E; Viitamaa T; Salonen JS; Sirviö J; Virtanen R
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):194-203. PubMed ID: 10208306
[TBL] [Abstract][Full Text] [Related]
34. Melatonin release from rat pineals in vitro is stimulated by both the alpha(2)-adrenoceptor agonist medetomidine and the antagonist atipamezole.
Mustanoja SM; Bäck N; Alila-Johansson A; Laakso ML
Eur J Pharmacol; 1999 Oct; 383(1):75-82. PubMed ID: 10556684
[TBL] [Abstract][Full Text] [Related]
35. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
Weinger MB; Segal IS; Maze M
Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
[TBL] [Abstract][Full Text] [Related]
36. Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats.
Carlson S; Tanila H; Rämä P; Mecke E; Pertovaara A
Behav Neural Biol; 1992 Sep; 58(2):113-9. PubMed ID: 1360798
[TBL] [Abstract][Full Text] [Related]
37. Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine.
Savola JM; Virtanen R
Eur J Pharmacol; 1991 Mar; 195(2):193-9. PubMed ID: 1678707
[TBL] [Abstract][Full Text] [Related]
38. Alpha 2-adrenoceptors and vigilance in cats: antagonism of medetomidine sedation by atipamezole.
Stenberg D; Porkka-Heiskanen T; Toppila J
Eur J Pharmacol; 1993 Jul; 238(2-3):241-7. PubMed ID: 8104808
[TBL] [Abstract][Full Text] [Related]
39. The effects of alpha-2 agonist, medetomidine and its antagonist, atipamezole on reaction and movement times in a visual choice reaction time task in monkeys.
Rämä P; Linnankoski I; Carlson S
Brain Res Bull; 1997; 44(2):171-5. PubMed ID: 9292207
[TBL] [Abstract][Full Text] [Related]
40. Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose.
Cullen LK
Br Vet J; 1996 Sep; 152(5):519-35. PubMed ID: 8885463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
